These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 19388973

  • 1. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.
    Hauber AB, Mohamed AF, Johnson FR, Falvey H.
    Diabet Med; 2009 Apr; 26(4):416-24. PubMed ID: 19388973
    [Abstract] [Full Text] [Related]

  • 2. Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes.
    Farmer A, Kinmonth AL, Sutton S.
    Diabet Med; 2006 Mar; 23(3):265-70. PubMed ID: 16492209
    [Abstract] [Full Text] [Related]

  • 3. Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences.
    Mohamed AF, Zhang J, Johnson FR, Lomon ID, Malvolti E, Townsend R, Ostgren CJ, Parhofer KG.
    Diabetes Metab; 2013 Oct; 39(5):397-403. PubMed ID: 23880594
    [Abstract] [Full Text] [Related]

  • 4. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR.
    Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
    [Abstract] [Full Text] [Related]

  • 5. Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study.
    Lawton J, Peel E, Parry O, Douglas M.
    Diabet Med; 2008 Apr; 25(4):491-5. PubMed ID: 18294222
    [Abstract] [Full Text] [Related]

  • 6. Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.
    Lund A, Knop FK.
    Curr Med Res Opin; 2012 May; 28(5):731-6. PubMed ID: 22462528
    [Abstract] [Full Text] [Related]

  • 7. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life.
    Pollack MF, Purayidathil FW, Bolge SC, Williams SA.
    Diabetes Res Clin Pract; 2010 Feb; 87(2):204-10. PubMed ID: 20036433
    [Abstract] [Full Text] [Related]

  • 8. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control.
    Tan MY, Magarey J.
    Patient Educ Couns; 2008 Aug; 72(2):252-67. PubMed ID: 18467068
    [Abstract] [Full Text] [Related]

  • 9. Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
    Russell-Jones D, Khan R.
    Diabetes Obes Metab; 2007 Nov; 9(6):799-812. PubMed ID: 17924864
    [Abstract] [Full Text] [Related]

  • 10. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.
    Chao J, Nau DP, Aikens JE.
    Clin Ther; 2007 Jan; 29(1):177-80. PubMed ID: 17379058
    [Abstract] [Full Text] [Related]

  • 11. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes.
    Chao J, Nau DP, Aikens JE, Taylor SD.
    Res Social Adm Pharm; 2005 Dec; 1(4):508-25. PubMed ID: 17138493
    [Abstract] [Full Text] [Related]

  • 12. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists.
    Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y.
    J Clin Pharm Ther; 2006 Oct; 31(5):409-19. PubMed ID: 16958818
    [Abstract] [Full Text] [Related]

  • 13. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 14. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
    Guimarães C, Marra CA, Colley L, Gill S, Simpson SH, Meneilly GS, Queiroz RH, Lynd LD.
    Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
    [Abstract] [Full Text] [Related]

  • 15. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes.
    Mateo JF, Gil-Guillén VF, Mateo E, Orozco D, Carbayo JA, Merino J.
    Int J Clin Pract; 2006 Apr; 60(4):422-8. PubMed ID: 16620354
    [Abstract] [Full Text] [Related]

  • 16. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain.
    Marrett E, Stargardt T, Mavros P, Alexander CM.
    Diabetes Obes Metab; 2009 Dec; 11(12):1138-44. PubMed ID: 19758360
    [Abstract] [Full Text] [Related]

  • 17. Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.
    Gelhorn HL, Stringer SM, Brooks A, Thompson C, Monz BU, Boye KS, Hach T, Lund SS, Palencia R.
    Diabetes Obes Metab; 2013 Sep; 15(9):802-9. PubMed ID: 23464623
    [Abstract] [Full Text] [Related]

  • 18. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk.
    Peters AL.
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S20-7. PubMed ID: 19952300
    [Abstract] [Full Text] [Related]

  • 19. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP, Chao J, Aikens JE.
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [Abstract] [Full Text] [Related]

  • 20. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL.
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.